Early Phase APIs

Early phase development of APIs is a very dynamic process in drug development and Customer proximity is important to accelerate early stage development and ease production scale up.

We have significant experience in the first time scale-up of APIs. We take a proactive approach to pharmaceutical process development and validation. We use our experience and expertise to efficiently bring your small molecule intermediates and APIs from early clinical phase to commercial production.

SinoGene team have extensive experience in designing and optimising processes for efficiency, robustness, safety, environmental impact and cost. An investment in Process development research often reduces the cost of goods associated with an API through the optimisation or replacement of expensive and/or inefficient synthetic operations.

APIs and Intermediates

SinoGene has been started with the intention of being a “Trusted supplier of APIs and intermediates” there by achieving through sustainable chemistry .

List of products Coming soon…

Speciality Chemicals

Coming soon...